Developer docs
API playgroundTry for free, no card

Search company profiles

Arthritis National Research Foundation

Full company profile

uuid0006uza

Namestring
Arthritis National Research Foundation
Legal namestring
Arthritis National Research Foundation
Company typeenum
Private
Founded yearint
1952
Descriptiontext

Arthritis National Research Foundation (ANRF) is a 501(c)(3) non-profit research foundation founded in 1952 and headquartered in Irvine, California. Its core function is providing research grant funding to early-career scientists working on arthritis and related autoimmune diseases, addressing a documented funding gap for promising research and the career-establishment challenges faced by investigators entering the field. ANRF's stated impact metrics indicate that 98% of its grantees remain in science and over 87% of awardees secure follow-on funding for their ANRF-originated projects.

ANRF's product surface is organized around a small number of distinct offerings. The central product is the Research Grants Program, awarded through a website-based application process with review by a Scientific Advisory Board and approval by the Board of Directors. The foundation also operates Immune Boost Capital, a wholly-owned evergreen venture fund that provides proof-of-concept capital to early-stage therapies, diagnostics, and technologies for immune-mediated diseases, with 100% of returns reinvested into research. Supporting products include the "In the Rheum" podcast, a clinical trials information hub, the "60 Minutes to Save Millions" virtual fundraising event, and the annual Arthritis and Lupus Awareness Month campaign. ANRF's Scientific Advisory Board is composed of former ANRF grant recipients, creating a self-reinforcing review ecosystem.

The foundation operates on a donation-driven revenue model. Income is generated through individual donations, tribute gifts, matched giving campaigns (including a 1:1 match on its May 15, 2026 Day of Giving), and event ticket sales ($30 per ticket for the 2026 virtual fundraiser). ANRF markets through a multi-channel approach spanning social media (Facebook, X, Instagram, LinkedIn, Pinterest, YouTube), its curearthritis.org website, email, webinars, and celebrity/athlete partnerships. Geographic focus is the United States, and the foundation states that 2026 represents the largest investment and most grantees in its history, with record research funding applications received.

Short descriptiontext

Arthritis National Research Foundation is a 501(c)(3) non-profit that provides grant funding to early-career scientists researching arthritis and autoimmune diseases, while operating Immune Boost Capital, an evergreen venture fund reinvesting all returns into immune-related research.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersIrvine, United States
HQ citystring
Irvine
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
arthritis research funding, biomedical research grants, nonprofit research foundation, autoimmune disease research, medical research grants
Industry3 codes
1Health & Medical Research Grantmaking Foundations
CodeBPAGAKALPrimaryYes
2Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryNo
3Research & Science Grantmaking Foundations
CodeBPAGAKAIPrimaryNo
NAICS code2 codes
  • Voluntary Health Organizations813212
  • Grantmaking and Giving Services81321
SIC code1 code
  • Services-Social Services8300
Product category
Nonprofit Medical Research Foundation
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Charitable Contributions
TypeGrants Donations
Description

ANRF raises funds through individual donations, tribute gifts in honor of others, and special giving campaigns such as matched giving days. The foundation operates with 100% of returns from its Immune Boost Capital venture fund reinvested into arthritis and autoimmune disease research.

curearthritis.org
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Others, Operations, Marketing or Sales, Personnel
Pricing details1 tier
1Virtual fundraiser tickets for '60 Minutes to Save Millions' event
ModelOtherBilling cadenceOne time
Notes

$30 per ticket for virtual fundraising event on March 26, 2026

einpresswire.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

ANRF provides research grant funding to early-career scientists conducting research on arthritis and autoimmune diseases, with the goal of advancing treatments and finding cures. The foundation also operates Immune Boost Capital, an evergreen venture fund that invests in early-stage autoimmune disease therapeutics and diagnostics, reinvesting 100% of returns to sustain ongoing research funding.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 98% of ANRF grantees stay in science
+3 more records
Product overview1 text field

The Arthritis National Research Foundation (ANRF) operates as a research funding organization rather than a traditional product company. ANRF's primary offerings include research grants for early-career scientists focused on arthritis and autoimmune diseases, an evergreen venture fund called Immune Boost Capital that supports early-stage therapeutics and diagnostics, virtual fundraising events like '60 Minutes to Save Millions', annual awareness campaigns including Arthritis and Lupus Awareness Month, and educational resources such as the 'In the Rheum' podcast and clinical trials information hub. The foundation's model reinvests all returns from its venture fund to sustain continuous innovation in immune-related disease research.

Product and service2 records
1Research Grants Program
CategoryResearch Grants
Description

ANRF's core research grant program that funds early-career scientists conducting research to improve treatments and find a cure for arthritis and related autoimmune diseases, supporting researchers in establishing sustainable research careers. Applications are submitted through the website and reviewed by the Scientific Advisory Board.

2Immune Boost Capital
CategoryImpact Investment Fund
Description

ANRF's evergreen venture fund that supports early-stage autoimmune disease therapeutics and diagnostics by providing proof-of-concept capital and reinvesting 100% of returns to sustain innovation in immune-related disease research.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers9 records
TypeDirect peer
Description

The largest U.S. nonprofit focused on arthritis, funding research, advocacy, and patient programs. Directly comparable to ANRF in mission area and donor base, but at substantially larger scale.

TypeDirect peer
Description

Funds psoriatic disease and psoriatic arthritis research while running patient advocacy programs. Comparable nonprofit grantmaking model for a specific autoimmune condition overlapping ANRF's research scope.

TypeOthers
Description

Disease-focused nonprofit famous for pioneering the venture philanthropy model that ANRF's Immune Boost Capital emulates. Strategically comparable as the archetype for nonprofit-led biotech investment.

TypeDirect peer
Description

Largest nonprofit funder of lupus research worldwide, with a similar grantmaking model focused on autoimmune disease. Comparable in disease-specific focus and early-career funding strategy.

TypeDirect peer
Description

Disease-specific nonprofit funding Sjögren's research, explicitly listed among ANRF's focus areas. Comparable mission, donor base, and grantmaking structure.

TypeBroad incumbent
Description

Professional society for rheumatologists that runs research, training, and policy programs. Comparable as a rheumatology ecosystem incumbent, though more clinician-focused than ANRF's donor-driven model.

TypeOthers
Description

Nonprofit funding spinal muscular atrophy research with a similar model combining research grants, patient education, and donor-driven fundraising. Comparable as a small, disease-specific research funding charity.

TypeDirect peer
Description

Nonprofit supporting scleroderma research and patients. Operates a similar grantmaking-plus-patient-services model to ANRF in an adjacent autoimmune disease area.

TypeDirect peer
Description

The research arm of the American College of Rheumatology, funding rheumatology research and training. Closely comparable to ANRF in funding early-career researchers studying rheumatic and autoimmune diseases.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Arthritis National Research Foundation

Nonprofit Medical Research Foundationcurearthritis.org

Arthritis National Research Foundation is a 501(c)(3) non-profit that provides grant funding to early-career scientists researching arthritis and autoimmune diseases, while operating Immune Boost Capital, an evergreen venture fund reinvesting all returns into immune-related research.

What Arthritis National Research Foundation does

Arthritis National Research Foundation (ANRF) is a 501(c)(3) non-profit research foundation founded in 1952 and headquartered in Irvine, California. Its core function is providing research grant funding to early-career scientists working on arthritis and related autoimmune diseases, addressing a documented funding gap for promising research and the career-establishment challenges faced by investigators entering the field. ANRF's stated impact metrics indicate that 98% of its grantees remain in science and over 87% of awardees secure follow-on funding for their ANRF-originated projects.

ANRF's product surface is organized around a small number of distinct offerings. The central product is the Research Grants Program, awarded through a website-based application process with review by a Scientific Advisory Board and approval by the Board of Directors. The foundation also operates Immune Boost Capital, a wholly-owned evergreen venture fund that provides proof-of-concept capital to early-stage therapies, diagnostics, and technologies for immune-mediated diseases, with 100% of returns reinvested into research. Supporting products include the "In the Rheum" podcast, a clinical trials information hub, the "60 Minutes to Save Millions" virtual fundraising event, and the annual Arthritis and Lupus Awareness Month campaign. ANRF's Scientific Advisory Board is composed of former ANRF grant recipients, creating a self-reinforcing review ecosystem.

The foundation operates on a donation-driven revenue model. Income is generated through individual donations, tribute gifts, matched giving campaigns (including a 1:1 match on its May 15, 2026 Day of Giving), and event ticket sales ($30 per ticket for the 2026 virtual fundraiser). ANRF markets through a multi-channel approach spanning social media (Facebook, X, Instagram, LinkedIn, Pinterest, YouTube), its curearthritis.org website, email, webinars, and celebrity/athlete partnerships. Geographic focus is the United States, and the foundation states that 2026 represents the largest investment and most grantees in its history, with record research funding applications received.

Arthritis National Research Foundation firmographics

Firmographics
Name
Arthritis National Research Foundation
Legal name
Arthritis National Research Foundation
Website
https://curearthritis.org
Company type
Private
Founded year
1952
Operating status
Operating
Headcount range
1–10 employees
Short description
Arthritis National Research Foundation is a 501(c)(3) non-profit that provides grant funding to early-career scientists researching arthritis and autoimmune diseases, while operating Immune Boost Capital, an evergreen venture fund reinvesting all returns into immune-related research.
Ownership category
akta.pro rank

Arthritis National Research Foundation industry classification

Industry
Product category
Nonprofit Medical Research Foundation
NAICS
Voluntary Health Organizations (813212), Grantmaking and Giving Services (81321)
SIC
Services-Social Services (8300)
akta.pro primary industry
Health & Medical Research Grantmaking Foundations (BPAGAKAL)
akta.pro secondary industries
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA), Research & Science Grantmaking Foundations (BPAGAKAI)

Keywords

  • Arthritis research funding
  • Biomedical research grants
  • Nonprofit research foundation
  • Autoimmune disease research
  • Medical research grants

Where Arthritis National Research Foundation is headquartered

Location

Headquarters

HQ city
Irvine
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Arthritis National Research Foundation business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Others, Operations, Marketing or Sales, Personnel

Revenue model

  1. Donations and Charitable Contributions: ANRF raises funds through individual donations, tribute gifts in honor of others, and special giving campaigns such as matched giving days. The foundation operates with 100% of returns from its Immune Boost Capital venture fund reinvested into arthritis and autoimmune disease research.

Pricing tiers

ModelBillingPrice
OtherOne timeVirtual fundraiser tickets for '60 Minutes to Save Millions' event

Go-to-market motion1 record

Distribution channels1 record

Marketing channels7 records

Arthritis National Research Foundation product offering

Product offering

Core offering

ANRF provides research grant funding to early-career scientists conducting research on arthritis and autoimmune diseases, with the goal of advancing treatments and finding cures. The foundation also operates Immune Boost Capital, an evergreen venture fund that invests in early-stage autoimmune disease therapeutics and diagnostics, reinvesting 100% of returns to sustain ongoing research funding.

Product overview

The Arthritis National Research Foundation (ANRF) operates as a research funding organization rather than a traditional product company. ANRF's primary offerings include research grants for early-career scientists focused on arthritis and autoimmune diseases, an evergreen venture fund called Immune Boost Capital that supports early-stage therapeutics and diagnostics, virtual fundraising events like '60 Minutes to Save Millions', annual awareness campaigns including Arthritis and Lupus Awareness Month, and educational resources such as the 'In the Rheum' podcast and clinical trials information hub. The foundation's model reinvests all returns from its venture fund to sustain continuous innovation in immune-related disease research.

Differentiator

Problem solved

Functional benefit

Products and services

  • Research Grants Program ANRF's core research grant program that funds early-career scientists conducting research to improve treatments and find a cure for arthritis and related autoimmune diseases, supporting researchers in establishing sustainable research careers. Applications are submitted through the website and reviewed by the Scientific Advisory Board.
  • Immune Boost Capital ANRF's evergreen venture fund that supports early-stage autoimmune disease therapeutics and diagnostics by providing proof-of-concept capital and reinvesting 100% of returns to sustain innovation in immune-related disease research.

Quantifiable outcome

  • 98% of ANRF grantees stay in science
  • +3 more outcomes

Companies that use Arthritis National Research Foundation

Customer profile

Segments3 records

Ideal customer profiles3 records

Arthritis National Research Foundation technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Arthritis National Research Foundation partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves5 records

Expansion highlights5 records

Arthritis National Research Foundation competitors and assessment

Company assessment

Direct peers

  • Arthritis Foundation: The largest U.S. nonprofit focused on arthritis, funding research, advocacy, and patient programs. Directly comparable to ANRF in mission area and donor base, but at substantially larger scale.
  • National Psoriasis Foundation: Funds psoriatic disease and psoriatic arthritis research while running patient advocacy programs. Comparable nonprofit grantmaking model for a specific autoimmune condition overlapping ANRF's research scope.
  • Lupus Research Alliance: Largest nonprofit funder of lupus research worldwide, with a similar grantmaking model focused on autoimmune disease. Comparable in disease-specific focus and early-career funding strategy.
  • Sjögren's Foundation: Disease-specific nonprofit funding Sjögren's research, explicitly listed among ANRF's focus areas. Comparable mission, donor base, and grantmaking structure.
  • Scleroderma Foundation: Nonprofit supporting scleroderma research and patients. Operates a similar grantmaking-plus-patient-services model to ANRF in an adjacent autoimmune disease area.
  • Rheumatology Research Foundation: The research arm of the American College of Rheumatology, funding rheumatology research and training. Closely comparable to ANRF in funding early-career researchers studying rheumatic and autoimmune diseases.

Others

  • Cystic Fibrosis Foundation: Disease-focused nonprofit famous for pioneering the venture philanthropy model that ANRF's Immune Boost Capital emulates. Strategically comparable as the archetype for nonprofit-led biotech investment.
  • Cure SMA: Nonprofit funding spinal muscular atrophy research with a similar model combining research grants, patient education, and donor-driven fundraising. Comparable as a small, disease-specific research funding charity.

Broad incumbents

  • American College of Rheumatology: Professional society for rheumatologists that runs research, training, and policy programs. Comparable as a rheumatology ecosystem incumbent, though more clinician-focused than ANRF's donor-driven model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Arthritis National Research Foundation social profiles

Digital presence

Arthritis National Research Foundation financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Arthritis National Research Foundation leadership team

Management profile

Number of profiles

Profiles3 records

Arthritis National Research Foundation subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Arthritis National Research Foundation funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Arthritis National Research Foundation M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Arthritis National Research Foundation

What does Arthritis National Research Foundation do?

ANRF provides research grant funding to early-career scientists conducting research on arthritis and autoimmune diseases, with the goal of advancing treatments and finding cures. The foundation also operates Immune Boost Capital, an evergreen venture fund that invests in early-stage autoimmune disease therapeutics and diagnostics, reinvesting 100% of returns to sustain ongoing research funding.

Is Arthritis National Research Foundation a public or private company?

Arthritis National Research Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was Arthritis National Research Foundation founded?

Arthritis National Research Foundation was founded in 1952. It employs 1 to 10 people.

Where is Arthritis National Research Foundation based?

Arthritis National Research Foundation is headquartered in Irvine, United States, in the North America region.

How does Arthritis National Research Foundation make money?

One revenue line is on record: donations and Charitable Contributions.

Who are Arthritis National Research Foundation's main competitors?

Direct peers on record are Arthritis Foundation, National Psoriasis Foundation, Lupus Research Alliance, Sjögren's Foundation, Scleroderma Foundation and Rheumatology Research Foundation. Others are Cystic Fibrosis Foundation and Cure SMA. American College of Rheumatology is listed as a broad incumbent.

Does Arthritis National Research Foundation have an API?

No public API is recorded for Arthritis National Research Foundation.

What industry is Arthritis National Research Foundation in?

Arthritis National Research Foundation's product category is Nonprofit Medical Research Foundation. Its primary akta.pro industry code is BPAGAKAL, Health & Medical Research Grantmaking Foundations, with a secondary code of BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS). Its NAICS code is 813212 and its SIC code is 8300.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireANRF Announces Largest Scholar Cohort and Research Investment in Foundation HistoryANRF announced its 2026-2027 scholar cohort of 24 early-career investigators selected from 131 applications, the largest class in foundation history. The funding spans four grant mechanisms, including $125,000 per year for two years, and builds on $36 million invested since the 1970s.EIN PresswireANRF Hosts First-Ever Virtual Fundraiser Amid Record Research ApplicationsThe Arthritis National Research Foundation (ANRF) announced it will host its first-ever virtual fundraiser, "60 Minutes to Save Millions," on March 26, 2026, coinciding with record applications for arthritis and autoimmune disease research funding. The event will feature former Detroit Lions offensive lineman Tyrell Crosby, who suffered a career-ending spinal injury at 24 and now advocates for the arthritis patient community. Tickets are priced at $30, with proceeds directly funding this year's record cohort of early-career researchers.EIN PresswireArthritis National Research Foundation Appoints Schalon Newton, DBA, as Principal of Immune Boost CapitalThe Arthritis National Research Foundation appointed Schalon Newton, DBA as Principal of Immune Boost Capital, a newly established philanthropic evergreen venture fund targeting early-stage autoimmune disease research. IBC was created to bridge the funding gap between academic discovery and commercial development by providing up to $500,000 in proof-of-concept capital per company, with a unique model that reinvests 100% of returns to sustain innovation. Dr. Newton brings over 30 years of life sciences leadership experience from Trefoil Therapeutics, Santen Inc., and Allergan Pharmaceuticals to guide this initiative addressing a critical translational funding gap that has stalled promising therapeutic approaches.PR NewswireThe Latest Discoveries in Rheumatology Research at the Arthritis National Research Foundation 2023 Research Scholar SymposiumThe Arthritis National Research Foundation is hosting its 2023 Research Scholar Symposium in Boston on March 11 to showcase recent discoveries in arthritis and autoimmune diseases. The event features presentations from industry experts at Sonoma Biotherapeutics, Pfizer Inc., and Janssen Pharmaceuticals, alongside academic researchers. The symposium aims to facilitate collaboration between scholars and industry leaders to advance treatment options for the 58.5 million Americans affected by arthritis.PR NewswireArthritis National Research Foundation (ANRF) 2023-2024 Grant Application Process Now OpenThe Arthritis National Research Foundation (ANRF) announced the opening of its 2023-2024 research grant application process, inviting early-career investigators to apply for funding across various arthritis-related research areas. The foundation increased its award amount to $125,000 per year, renewable for two years, recognizing the rising costs and demands faced by researchers. Applications must be submitted online by January 20, 2023 through ProposalCentral via CureArthritis.org.PR NewswireNational Psoriasis Foundation Awards 2016 Grants and FellowshipsThe National Psoriasis Foundation awarded over $1.9 million in research grants and fellowships in 2016, supporting 23 new projects focused on advancing psoriatic disease research. The grants were distributed across multiple categories including Discovery Grants, Translational Research Grants, Early Career Research Grants, and Fellowship Programs for researchers investigating novel treatments, genetic basis of psoriatic disease, and related conditions. Collaborating partners including the Arthritis National Research Foundation and Amgen co-funded specific grants, while the NIH partnered on a translational medicine fellowship.GlobeNewswireRepresentatives From the Arthritis National Research Foundation to Ring The NASDAQ Stock Market Opening BellRepresentatives from the Arthritis National Research Foundation and supporters will ring the NASDAQ opening bell on July 8, 2010, at 9:15 a.m. ET at NASDAQ MarketSite. The event is broadcast on Galaxy 19 C/15 and Ascent fiber 1623, with a webcast available at NASDAQ.com.